Abstract

Survivin’s dual function as apoptosis inhibitor and regulator of cell proliferation is mediated via its interaction with the export receptor CRM1. This protein–protein interaction represents an attractive target in cancer research and therapy. Here, we report a sophisticated strategy addressing Survivin’s nuclear export signal (NES), the binding site of CRM1, with advanced supramolecular tweezers for lysine and arginine. These were covalently connected to small peptides resembling the natural, self-complementary dimer interface which largely overlaps with the NES. Several biochemical methods demonstrated sequence-selective NES recognition and interference with the critical receptor interaction. These data were strongly supported by molecular dynamics simulations and multiscale computational studies. Rational design of lysine tweezers equipped with a peptidic recognition element thus allowed to address a previously unapproachable protein surface area. As an experimental proof-of-principle for specific transport signal interference, this concept should be transferable to any protein epitope with a flanking well-accessible lysine.

Survivin’s dual function as apoptosis inhibitor and regulator of cell proliferation is mediated via its interaction with the export receptor CRM1. Here authors report a strategy addressing its dimer interface overlapping with the nuclear export signal, the binding site of CRM1, with advanced supramolecular tweezers for lysine and arginine.

Details

Title
Specific inhibition of the Survivin–CRM1 interaction by peptide-modified molecular tweezers
Author
Meiners Annika 1 ; Bäcker, Sandra 1   VIAFID ORCID Logo  ; Inesa, Hadrović 2 ; Heid, Christian 2 ; Beuck, Christine 3   VIAFID ORCID Logo  ; Ruiz-Blanco, Yasser B 4 ; Mieres-Perez, Joel 4   VIAFID ORCID Logo  ; Pörschke Marius 3   VIAFID ORCID Logo  ; Grad Jean-Noël 5 ; Vallet, Cecilia 1 ; Hoffmann, Daniel 5   VIAFID ORCID Logo  ; Bayer, Peter 3   VIAFID ORCID Logo  ; Sánchez-García Elsa 4   VIAFID ORCID Logo  ; Schrader, Thomas 2   VIAFID ORCID Logo  ; Knauer, Shirley K 1   VIAFID ORCID Logo 

 University of Duisburg-Essen, Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
 University of Duisburg-Essen, Institute of Organic Chemistry I, Faculty of Chemistry, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
 University of Duisburg-Essen, Department of Structural and Medicinal Biology, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
 University of Duisburg-Essen, Department of Computational Biochemistry, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
 University of Duisburg-Essen, Department of Bioinformatics and Computational Biophysics, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2498796058
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.